האיגוד הישראלי לרפואת משפחה
כעת 6836 ערכים
רופאים, הרשמו עכשיו למועדון העורכים כניסה עקבו אחרינו בפייסבוק
האיגוד הישראלי לרפואת משפחה
רופאים, הרשמו עכשיו למועדון העורכים כניסה עקבו אחרינו בפייסבוק
כעת 6836 ערכים
האיגוד הישראלי לרפואת משפחה

הבדלים בין גרסאות בדף "קוד ATC code - ATC"

מתוך ויקירפואה
שורה 2,058: שורה 2,058:
 
|Empty  
 
|Empty  
 
|}
 
|}
−
==gg==
 
−
{|
 
 
|-
 
|-
 
|
 
|
שורה 2,069: שורה 2,067:
 
|-
 
|-
 
|
 
|
 +
|
 +
|A06A
 +
|
 +
|
 +
|[[Drugs for constipation]]
 +
|-
 +
|
 +
|
 +
|
 +
|A06AA
 +
|
 +
|[[Softeners, emollients]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AA01
 +
|[[Liquid paraffin]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AA02
 +
|[[Docusate sodium]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AA51
 +
|[[Liquid paraffin, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|A06AB
 +
|
 +
|[[Contact laxatives]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB01
 +
|[[Oxyphenisatine]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB02
 +
|[[Bisacodyl]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB03
 +
|[[Dantron]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB04
 +
|[[Phenolphthalein]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB05
 +
|[[Castor oil]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB06
 +
|[[Senna glycosides]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB07
 +
|[[Cascara]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB08
 +
|[[Sodium picosulfate]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB09
 +
|[[Bisoxatin]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB20
 +
|[[Contact laxatives in combination]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB30
 +
|[[Contact laxatives in combination with belladonna alkaloids]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB52
 +
|[[Bisacodyl, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB53
 +
|[[Dantron, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB56
 +
|[[Senna glycosides, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB57
 +
|[[Cascara, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AB58
 +
|[[Sodium picosulfate, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|A06AC
 +
|
 +
|[[Bulk-forming laxatives]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AC01
 +
|[[Ispaghula (psylla seeds)]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AC02
 +
|[[Ethulose]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AC03
 +
|[[Sterculia]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AC05
 +
| [[Linseed]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AC06
 +
|[[Methylcellulose]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AC07
 +
|[[Triticum (wheat fibre)]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AC08
 +
|[[Polycarbophil calcium]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AC51
 +
|[[Ispaghula, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AC53
 +
|[[Sterculia, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AC55
 +
|[[Linseed, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|A06AD
 +
|
 +
|[[Osmotically acting laxatives]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD01
 +
|[[Magnesium carbonate]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD02
 +
|[[Magnesium oxide]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD03
 +
|[[Magnesium peroxide]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD04
 +
|[[Magnesium sulfate]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD10
 +
|[[Mineral salts in combination]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD11
 +
|[[Lactulose]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD12
 +
|[[Lactitol]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD13
 +
|[[Sodium sulfate]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD14
 +
|[[Pentaerithrityl]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD15
 +
|[[Macrogol]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD16
 +
|[[Mannitol]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD17
 +
|[[Sodium phosphate]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD18
 +
|[[Sorbitol]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD19
 +
|[[Magnesium citrate]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD21
 +
|[[Sodium tartrate]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD61
 +
|[[Lactulose, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AD65
 +
|[[Macrogol, combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|A06AG
 +
|
 +
|[[Enemas]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AG01
 +
|[[Sodium phosphate]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AG02
 +
|[[Bisacodyl]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AG03
 +
|[[Dantron, including combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AG04
 +
|[[Glycerol]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AG06
 +
|[[Oil]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AG07
 +
|[[Sorbitol]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AG10
 +
|[[Docusate sodium, including combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AG11
 +
|[[Laurilsulfate, including combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AG20
 +
|[[Combinations]]
 +
|-
 +
|
 +
|
 +
|
 +
|A06AH
 +
|
 +
|[[Peripheral opioid receptor antagonists]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AH01
 +
|[[Methylnaltrexone bromide]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AH02
 +
|[[Alvimopan]]
 +
|-
 +
|
 +
|
 +
|
 +
|A06AX
 +
|
 +
|[[Other drugs for constipation]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AX01
 +
|[[Glycerol]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AX02
 +
|[[Carbon dioxide producing drugs]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AX03
 +
|[[Lubiprostone]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AX04
 +
|[[Linaclotide]]
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|A06AX05
 +
|[[Prucalopride]]
 +
|-
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|A06A Drugs for constipation
+
|A06AX06
−
 
+
|[[Tegaserod]]
−
A06AA Softeners, emollients
 
−
A06AA01 Liquid paraffin
 
−
A06AA02 Docusate sodium
 
−
A06AA51 Liquid paraffin, combinations
 
−
A06AB Contact laxatives
 
−
A06AB01 Oxyphenisatine
 
−
A06AB02 Bisacodyl
 
−
A06AB03 Dantron
 
−
A06AB04 Phenolphthalein
 
−
A06AB05 Castor oil
 
−
A06AB06 Senna glycosides
 
−
A06AB07 Cascara
 
−
A06AB08 Sodium picosulfate
 
−
A06AB09 Bisoxatin
 
−
A06AB20 Contact laxatives in combination
 
−
A06AB30 Contact laxatives in combination with belladonna alkaloids
 
−
A06AB52 Bisacodyl, combinations
 
−
A06AB53 Dantron, combinations
 
−
A06AB56 Senna glycosides, combinations
 
−
A06AB57 Cascara, combinations
 
−
A06AB58 Sodium picosulfate, combinations
 
−
A06AC Bulk-forming laxatives
 
−
A06AC01 Ispaghula (psylla seeds)
 
−
A06AC02 Ethulose
 
−
A06AC03 Sterculia
 
−
A06AC05 Linseed
 
−
A06AC06 Methylcellulose
 
−
A06AC07 Triticum (wheat fibre)
 
−
A06AC08 Polycarbophil calcium
 
−
A06AC51 Ispaghula, combinations
 
−
A06AC53 Sterculia, combinations
 
−
A06AC55 Linseed, combinations
 
−
A06AD Osmotically acting laxatives
 
−
A06AD01 Magnesium carbonate
 
−
A06AD02 Magnesium oxide
 
−
A06AD03 Magnesium peroxide
 
−
A06AD04 Magnesium sulfate
 
−
A06AD10 Mineral salts in combination
 
−
A06AD11 Lactulose
 
−
A06AD12 Lactitol
 
−
A06AD13 Sodium sulfate
 
−
A06AD14 Pentaerithrityl
 
−
A06AD15 Macrogol
 
−
A06AD16 Mannitol
 
−
A06AD17 Sodium phosphate
 
−
A06AD18 Sorbitol
 
−
A06AD19 Magnesium citrate
 
−
A06AD21 Sodium tartrate
 
−
A06AD61 Lactulose, combinations
 
−
A06AD65 Macrogol, combinations
 
−
A06AG Enemas
 
−
A06AG01 Sodium phosphate
 
−
A06AG02 Bisacodyl
 
−
A06AG03 Dantron, including combinations
 
−
A06AG04 Glycerol
 
−
A06AG06 Oil
 
−
A06AG07 Sorbitol
 
−
A06AG10 Docusate sodium, including combinations
 
−
A06AG11 Laurilsulfate, including combinations
 
−
A06AG20 Combinations
 
−
A06AH Peripheral opioid receptor antagonists
 
−
A06AH01 Methylnaltrexone bromide
 
−
A06AH02 Alvimopan
 
−
A06AX Other drugs for constipation
 
−
A06AX01 Glycerol
 
−
A06AX02 Carbon dioxide producing drugs
 
−
A06AX03 Lubiprostone
 
−
A06AX04 Linaclotide
 
−
A06AX05 Prucalopride
 
−
A06AX06 Tegaserod
 
 
|-
 
|-
 
|
 
|

גרסה מ־19:22, 14 באוקטובר 2013

מפתח קודי ATC


גישה מהירה A / B / C / D / G / H / J / L / M / N / P / R / S / V

  • הטבלא ניתנת למיון לפי כל אחת מהעמודות
1st level 2nd level 3rd level 4th level 5th level Contents
‏A Alimentary tract and metabolism
A01 Stomatological preparations
A01A Stomatological preparations
A01AA Caries prophylactic agents
A01AA01 Sodium fluoride
A01AA02 Sodium monofluorophosphate
A01AA03 Olaflur
A01AA04 Stannous fluoride
A01AA30 Combinations
A01AA51 Sodium fluoride, combinations
A01AB Anti-infectives and antiseptics for local oral treatment
A01AB02 Hydrogen peroxide
A01AB03 Chlorhexidine
A01AB04 Amphotericin B
A01AB05 Polynoxylin
A01AB06 Domiphen
A01AB07 Oxyquinoline
A01AB08 Neomycin
A01AB09 Miconazole
A01AB10 Natamycin
A01AB11 Various
A01AB12 Hexetidine
A01AB13 Tetracycline
A01AB14 Benzoxonium chloride
A01AB15 Tibezonium iodide
A01AB16 Mepartricin
A01AB17 Metronidazole
A01AB18 Clotrimazole
A01AB19 Sodium perborate
A01AB21 Chlortetracycline
A01AB22 Doxycycline
A01AB23 Minocycline
A01AC Corticosteroids for local oral treatment
A01AC01 Triamcinolone
A01AC02 Dexamethasone
A01AC03 Hydrocortisone
A01AC54 Prednisolone, combinations
A01AD Other agents for local oral treatment
A01AD01 Epinephrine
A01AD02 Benzydamine
A01AD05 Acetylsalicylic acid
A01AD06 Adrenalone
A01AD07 Amlexanox
A01AD08 Becaplermin
A01AD11 Various
A02 Drugs for acid related disorders
A02A Antacids
A02AA Magnesium compounds
A02AA01 Magnesium carbonate
A02AA02 Magnesium oxide
A02AA03 Magnesium peroxide
A02AA04 Magnesium hydroxide
A02AA05 Magnesium silicate
A02AA10 Combinations
A02AB Aluminium compounds
A02AB01 Aluminium hydroxide
A02AB02 Algeldrate
A02AB03 Aluminium phosphate
A02AB04 Dihydroxialumini sodium carbonate
A02AB05 Aluminium acetoacetate
A02AB06 Aloglutamol
A02AB07 Aluminium glycinate
A02AB10 Combinations
A02AC Calcium compounds
A02AC01 Calcium carbonate
A02AC02 Calcium silicate
A02AC10 Combinations
A02AD Combinations and complexes of aluminium, calcium and magnesium compounds
A02AD01 Ordinary salt combinations
A02AD02 Magaldrate
A02AD03 Almagate
A02AD04 Hydrotalcite
A02AD05 Almasilate
A02AF Antacids with antiflatulents
A02AF01 Magaldrate and antiflatulents
A02AF02 Ordinary salt combinations and antiflatulents
A02AG Antacids with antispasmodics
Empty
A02AH Antacids with sodium bicarbonate
Empty
A02AX Antacids, other combinations
Empty
A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A02BA H2-receptor antagonists
A02BA01 Cimetidine
A02BA02 Ranitidine
A02BA03 Famotidine
A02BA04 Nizatidine
A02BA05 Niperotidine
A02BA06 Roxatidine
A02BA07 Ranitidine bismuth citrate
A02BA08 Lafutidine
A02BA51 Cimetidine, combinations
A02BA53 Famotidine, combinations
A02BB Prostaglandins
A02BB01 Misoprostol
A02BB02 Enprostil
A02BC Proton pump inhibitors
A02BC01 Omeprazole
A02BC02 Pantoprazole
A02BC03 Lansoprazole
A02BC04 Rabeprazole
A02BC05 Esomeprazole
A02BC06 Dexlansoprazole
A02BD Combinations for eradication of Helicobacter pylori
A02BD01 Omeprazole, amoxicillin and metronidazole
A02BD02 Lansoprazole, tetracycline and metronidazole
A02BD03 Lansoprazole, amoxicillin and metronidazole
A02BD04 Pantoprazole, amoxicillin and clarithromycin
A02BD05 Omeprazole, amoxicillin and clarithromycin
A02BD06 Esomeprazole, amoxicillin and clarithromycin
A02BD07 Lansoprazole, amoxicillin and clarithromycin
A02BD08 Bismuth subcitrate, tetracycline and metronidazole
A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A02BX01 Carbenoxolone
A02BX02 Sucralfate
A02BX03 Pirenzepine
A02BX04 Methiosulfonium chloride
A02BX05 Bismuth subcitrate
A02BX06 Proglumide
A02BX07 Gefarnate
A02BX08 Sulglicotide
A02BX09 Acetoxolone
A02BX10 Zolimidine
A02BX11 Troxipide
A02BX12 Bismuth subnitrate
A02BX13 Alginic acid
A02BX51 Carbenoxolone, combinations excluding psycholeptics
A02BX71 Carbenoxolone, combinations with psycholeptics
A02BX77 Gefarnate, combinations with psycholeptics
A02X Other drugs for acid related disorders
Empty
A03 Drugs for functional gastrointestinal disorders
A03A Drugs for functional gastrointestinal disorders
A03AA Synthetic anticholinergics, esters with tertiary amino group
A03AA01 Oxyphencyclimine
A03AA03 Camylofin
A03AA04 Mebeverine
A03AA05 Trimebutine
A03AA06 Rociverine
A03AA07 Dicycloverine
A03AA08 Dihexyverine
A03AA09 Difemerine
A03AA30 Piperidolate
A03AB Synthetic anticholinergics, quaternary ammonium compounds
A03AB01 Benzilone
A03AB02 Glycopyrronium
A03AB03 Oxyphenonium
A03AB04 Penthienate
A03AB05 Propantheline
A03AB06 Otilonium bromide
A03AB07 Methantheline
A03AB08 Tridihexethyl
A03AB09 Isopropamide
A03AB10 Hexocyclium
A03AB11 Poldine
A03AB12 Mepenzolate
A03AB13 Bevonium
A03AB14 Pipenzolate
A03AB15 Diphemanil
A03AB16 (2-benzhydryloxyethyl)diethyl-methylammonium iodide
A03AB17 Tiemonium iodide
A03AB18 Prifinium bromide
A03AB19 Timepidium bromide
A03AB21 Fenpiverinium
A03AB53 Oxyphenonium, combinations
A03AC Synthetic antispasmodics, amides with tertiary amines
A03AC02 Dimethylaminopropionylphenothiazine
A03AC04 Nicofetamide
A03AC05 Tiropramide
A03AD Papaverine and derivatives
A03AD01 Papaverine
A03AD02 Drotaverine
A03AD30 Moxaverine
A03AE Serotonin receptor antagonists
A03AE01 Alosetron
A03AE03 Cilansetron
A03AX Other drugs for functional gastrointestinal disorders
A03AX01 Fenpiprane
A03AX02 Diisopromine
A03AX03 Chlorbenzoxamine
A03AX04 Pinaverium
A03AX05 Fenoverine
A03AX06 Idanpramine
A03AX07 Proxazole
A03AX08 Alverine
A03AX09 Trepibutone
A03AX10 Isometheptene
A03AX11 Caroverine
A03AX12 Phloroglucinol
A03AX13 Silicones
A03AX30 Trimethyldiphenylpropylamine
A03AX58 Alverine, combinations
A03B Belladonna and derivatives, plain
A03BA Belladonna alkaloids, tertiary amines
A03BA01 Atropine
A03BA03 Hyoscyamine
A03BA04 Belladonna total alkaloids
A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
A03BB01 Butylscopolamine
A03BB02 Methylatropine
A03BB03 Methylscopolamine
A03BB04 Fentonium
A03BB05 Cimetropium bromide
A03C Antispasmodics in combination with psycholeptics
A03CA Synthetic anticholinergic agents in combination with psycholeptics
A03CA01 Isopropamide and psycholeptics
A03CA02 Clidinium and psycholeptics
A03CA03 Oxyphencyclimine and psycholeptics
A03CA04 Otilonium bromide and psycholeptics
A03CA05 Glycopyrronium and psycholeptics
A03CA06 Bevonium and psycholeptics
A03CA07 Ambutonium and psycholeptics
A03CA08 Diphemanil and psycholeptics
A03CA30 Emepronium and psycholeptics
A03CA34 Propantheline and psycholeptics
A03CB Belladonna and derivatives in combination with psycholeptics
A03CB01 Methylscopolamine and psycholeptics
A03CB02 Belladonna total alkaloids and psycholeptics
A03CB03 Atropine and psycholeptics
A03CB04 Methylhomatropine and psycholeptics
A03CB31 Hyoscyamine and psycholeptics
A03CC Other antispasmodics in combination with psycholeptics
empty
A03D Antispasmodics in combination with analgesics
A03DA Synthetic anticholinergic agents in combination with analgesics
A03DA01 Tropenzilone and analgesics
A03DA02 Pitofenone and analgesics
A03DA03 Bevonium and analgesics
A03DA04 Ciclonium and analgesics
A03DA05 Camylofin and analgesics
A03DA06 Trospium and analgesics
A03DA07 Tiemonium iodide and analgesics
A03DB Belladonna and derivatives in combination with analgesics
A03DB04 Butylscopolamine and analgesics
A03DC Other antispasmodics in combination with analgesics
empty
A03E Antispasmodics and anticholinergics in combination with other drugs
A03EA Antispasmodics, psycholeptics and analgesics in combination
empty
A03ED Antispasmodics in combination with other drugs
empty
A03F Propulsives
A03FA Propulsives
A03FA01 Metoclopramide
A03FA02 Cisapride
A03FA03 Domperidone
A03FA04 Bromopride
A03FA05 Alizapride
A03FA06 Clebopride
A04 Antiemetics and antinauseants
A04A Antiemetics and antinauseants
A04AA Serotonin (5-HT3) antagonists
A04AA01 Ondansetron
A04AA02 Granisetron
A04AA03 Tropisetron
A04AA04 Dolasetron
A04AA05 Palonosetron
A04AD Other antiemetics
A04AD01 Scopolamine
A04AD02 Cerium oxalate
A04AD04 Chlorobutanol
A04AD05 Metopimazine
A04AD10 Dronabinol
A04AD11 Nabilone
A04AD12 Aprepitant
A04AD13 Casopitant
A04AD51 Scopolamine, combinations
A04AD54 Chlorobutanol, combinations
A05 Bile and liver therapy
A05A Bile therapy
A05AA Bile acid preparations
A05AA01 Chenodeoxycholic acid
A05AA02 Ursodeoxycholic acid
A05AA03 Cholic acid
A05AB Preparations for biliary tract therapy
A05AB01 Nicotinyl methylamide
A05AX Other drugs for bile therapy
A05AX01 Piprozolin
A05AX02 Hymecromone
A05AX03 Cyclobutyrol
A05B Liver therapy, lipotropics
A05BA Liver therapy
A05BA01 Arginine glutamate
A05BA03 Silymarin
A05BA04 Citiolone
A05BA05 Epomediol
A05BA06 Ornithine oxoglutarate
A05BA07 Tidiacic arginine
A05BA08 Glycyrrhizic acid (glycyrrhizin)
A05C Drugs for bile therapy and lipotropics in combination
Empty

|- | |A06 | | | |Drugs for constipation |- | | |A06A | | |Drugs for constipation |- | | | |A06AA | |Softeners, emollients |- | | | | |A06AA01 |Liquid paraffin |- | | | | |A06AA02 |Docusate sodium |- | | | | |A06AA51 |Liquid paraffin, combinations |- | | | |A06AB | |Contact laxatives |- | | | | |A06AB01 |Oxyphenisatine |- | | | | |A06AB02 |Bisacodyl |- | | | | |A06AB03 |Dantron |- | | | | |A06AB04 |Phenolphthalein |- | | | | |A06AB05 |Castor oil |- | | | | |A06AB06 |Senna glycosides |- | | | | |A06AB07 |Cascara |- | | | | |A06AB08 |Sodium picosulfate |- | | | | |A06AB09 |Bisoxatin |- | | | | |A06AB20 |Contact laxatives in combination |- | | | | |A06AB30 |Contact laxatives in combination with belladonna alkaloids |- | | | | |A06AB52 |Bisacodyl, combinations |- | | | | |A06AB53 |Dantron, combinations |- | | | | |A06AB56 |Senna glycosides, combinations |- | | | | |A06AB57 |Cascara, combinations |- | | | | |A06AB58 |Sodium picosulfate, combinations |- | | | |A06AC | |Bulk-forming laxatives |- | | | | |A06AC01 |Ispaghula (psylla seeds) |- | | | | |A06AC02 |Ethulose |- | | | | |A06AC03 |Sterculia |- | | | | |A06AC05 | Linseed |- | | | | |A06AC06 |Methylcellulose |- | | | | |A06AC07 |Triticum (wheat fibre) |- | | | | |A06AC08 |Polycarbophil calcium |- | | | | |A06AC51 |Ispaghula, combinations |- | | | | |A06AC53 |Sterculia, combinations |- | | | | |A06AC55 |Linseed, combinations |- | | | |A06AD | |Osmotically acting laxatives |- | | | | |A06AD01 |Magnesium carbonate |- | | | | |A06AD02 |Magnesium oxide |- | | | | |A06AD03 |Magnesium peroxide |- | | | | |A06AD04 |Magnesium sulfate |- | | | | |A06AD10 |Mineral salts in combination |- | | | | |A06AD11 |Lactulose |- | | | | |A06AD12 |Lactitol |- | | | | |A06AD13 |Sodium sulfate |- | | | | |A06AD14 |Pentaerithrityl |- | | | | |A06AD15 |Macrogol |- | | | | |A06AD16 |Mannitol |- | | | | |A06AD17 |Sodium phosphate |- | | | | |A06AD18 |Sorbitol |- | | | | |A06AD19 |Magnesium citrate |- | | | | |A06AD21 |Sodium tartrate |- | | | | |A06AD61 |Lactulose, combinations |- | | | | |A06AD65 |Macrogol, combinations |- | | | |A06AG | |Enemas |- | | | | |A06AG01 |Sodium phosphate |- | | | | |A06AG02 |Bisacodyl |- | | | | |A06AG03 |Dantron, including combinations |- | | | | |A06AG04 |Glycerol |- | | | | |A06AG06 |Oil |- | | | | |A06AG07 |Sorbitol |- | | | | |A06AG10 |Docusate sodium, including combinations |- | | | | |A06AG11 |Laurilsulfate, including combinations |- | | | | |A06AG20 |Combinations |- | | | |A06AH | |Peripheral opioid receptor antagonists |- | | | | |A06AH01 |Methylnaltrexone bromide |- | | | | |A06AH02 |Alvimopan |- | | | |A06AX | |Other drugs for constipation |- | | | | |A06AX01 |Glycerol |- | | | | |A06AX02 |Carbon dioxide producing drugs |- | | | | |A06AX03 |Lubiprostone |- | | | | |A06AX04 |Linaclotide |- | | | | |A06AX05 |Prucalopride |- | | | | |A06AX06 |Tegaserod |- | |A07 | | | |Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |- | | | | | |להשלים |- | |A08 | | | |Antiobesity preparations, excluding diet products |- | | | | | |להשלים |- | |A09 | | | |Digestives,including enzymes |- | | | | | |להשלים |- | |A10 | | | |Drugs used in diabetes |- | | |A10A | | |Insulins and analogues |- | | | |A10AB | |Insulins and analogues for injection, fast-acting |- | | | | |A10AB01 |Insulin (human) |- | | | | |A10AB02 |Insulin (beef) |- | | | | |A10AB03 |Insulin (pork) |- | | | | |A10AB04 |Insulin lispro |- | | | | |A10AB05 |Insulin aspart |- | | | | |A10AB06 |Insulin glulisine |- | | | | |A10AB30 |Combinations |- | | | |A10AC | |Insulins and analogues for injection, intermediate-acting |- | | | | |A10AC01 |Insulin (human) |- | | | | |A10AC02 |Insulin (beef) |- | | | | |A10AC03 |Insulin (pork) |- | | | | |A10AC04 |Insulin lispro |- | | | | |A10AC30 |Combinations |- | | | |A10AD | |Insulins and analogues for injection, intermediate-acting combined with fast-acting |- | | | | |A10AD01 |Insulin (human) |- | | | | |A10AD02 |Insulin (beef) |- | | | | |A10AD03 |Insulin (pork) |- | | | | |A10AD04 |Insulin lispro |- | | | | |A10AD05 |Insulin aspart |- | | | | |A10AD30 |Combinations |- | | | |A10AE | |Insulins and analogues for injection, long-acting |- | | | | |A10AE01 |Insulin (human) |- | | | | |A10AE02 |Insulin (beef) |- | | | | |A10AE03 |Insulin (pork) |- | | | | |A10AE04 |Insulin glargine |- | | | | |A10AE05 |Insulin detemir |- | | | | |A10AE30 |Combinations |- | | | |A10AF | |Insulins and analogues for inhalation |- | | | | |A10AF01 |Insulin (human) |- | | |A10B | | |Blood glucose lowering drugs, excluding insulins |- | | | |A10BA | |Biguanides |- | | | | |A10BA01 |Phenformin |- | | | | |A10BA02 |Metformin |- | | | | |A10BA03 |Buformin |- | | | |A10BB | |Sulfonamides, urea derivatives |- | | | | |A10BB01 |Glibenclamide |- | | | | |A10BB02 |Chlorpropamide |- | | | | |A10BB03 |Tolbutamide |- | | | | |A10BB04 |Glibornuride |- | | | | |A10BB05 |Tolazamide |- | | | | |A10BB06 |Carbutamide |- | | | | |A10BB07 |Glipizide |- | | | | |A10BB08 |Gliquidone |- | | | | |A10BB09 |Gliclazide |- | | | | |A10BB10 |Metahexamide |- | | | | |A10BB11 |Glisoxepide |- | | | | |A10BB12 |Glimepiride |- | | | | |A10BB31 |Acetohexamide |- | | | |A10BC | |Sulfonamides (heterocyclic) |- | | | | |A10BC01 |Glymidine |- | | | |A10BD | |Combinations of oral blood glucose lowering drugs |- | | | | |A10BD01 |Phenformin and sulfonamides |- | | | | |A10BD02 |Metformin and sulfonamides |- | | | | |A10BD03 |Metformin and rosiglitazone |- | | | | |A10BD04 |Glimepiride and rosiglitazone |- | | | | |A10BD05 |Metformin and pioglitazone |- | | | | |A10BD06 |Glimepiride and pioglitazone |- | | | | |A10BD07 |Metformin and sitagliptin |- | | | | |A10BD08 |Metformin and vildagliptin |- | | | | |A10BD09 |Pioglitazone and alogliptin |- | | | | |A10BD10 |Metformin and saxagliptin |- | | | | |A10BD11 |Metformin and linagliptin |- | | | | |A10BD12 |Pioglitazone and sitagliptin |- | | | | |A10BD13 |Metformin and alogliptin |- | | | |A10BF | |Alpha glucosidase inhibitors |- | | | | |A10BF01 |Acarbose |- | | | | |A10BF02 |Miglitol |- | | | | |A10BF03 |Voglibose |- | | | |A10BG | |Thiazolidinediones |- | | | | |A10BG01 |Troglitazone |- | | | | |A10BG02 |Rosiglitazone |- | | | | |A10BG03 |Pioglitazone |- | | | |A10BH | |Dipeptidyl peptidase 4 (DPP-4) inhibitors |- | | | | |A10BH01 |Sitagliptin |- | | | | |A10BH02 |Vildagliptin |- | | | | |A10BH03 |Saxagliptin |- | | | | |A10BH04 |Alogliptin |- | | | | |A10BH05 |Linagliptin |- | | | | |A10BH51 |Sitagliptin and simvastatin |- | | | |A10BX | |Other blood glucose lowering drugs, excluding insulins |- | | | | |A10BX01 |Guar gum |- | | | | |A10BX02 |Repaglinide |- | | | | |A10BX03 |Nateglinide |- | | | | |A10BX04 |Exenatide |- | | | | |A10BX05 |Pramlintide |- | | | | |A10BX06 |Benfluorex |- | | | | |A10BX07 |Liraglutide |- | | | | |A10BX08 |Mitiglinide |- | | | | |A10BX09 |Dapagliflozin |- | | |A10X | | |Other drugs used in diabetes |- | | | |A10XA | |Aldose reductase inhibitors |- | | | | |A10XA01 |Tolrestat |- | |A11 | | | |Vitamins |- | | | | | |להשלים |- | |A12 | | | |Mineral supplements |- | | |A12A | | |ֻCalcium |- | | | | | |להשלים |- | | |A12B | | |Potassium |- | | | | | |להשלים |- | | |A12C | | |Other mineral supplements |- | | | |A12CA | |Sodium |- | | | | | |להשלים |- | | | |A12CB | |Zinc |- | | | | | |להשלים |- | | | |A12CC | |Magnesium |- | | | | | |להשלים |- | | | |A12CD | |Fluoride |- | | | | | |להשלים |- | | | |A12CE | |Selenium |- | | | | | |להשלים |- | | | |A12CX | |Other mineral products |- | | | | | |להשלים |- | |A13 | | | |Tonics |- | | |A13A | | |Tonics |- | | | | | |empty |- | |A14 | | | |Anabolic agents for systemic use |- | | | | | |להשלים |- | |A15 | | | |Appetite stimulants |- | | | | | |empty |- | |A16 | | | |Other alimentary tract and metabolism products |- | | | | | |להשלים |- |‏B | | | | |Blood and blood forming organs ‏ |- | |B01 | | | |Antithrombotic agents |- | | |B01A | | |Antithrombotic agents |- | | | |B01AA | |Vitamin K antagonists |- | | | | |B01AA01 |Dicoumarol |- | | | | |B01AA02 |Phenindione |- | | | | |B01AA03 |Warfarin |- | | | | |B01AA04 |Phenprocoumon |- | | | | |B01AA07 |Acenocoumarol |- | | | | |B01AA08 |Ethyl biscoumacetate |- | | | | |B01AA09 |Clorindione |- | | | | |B01AA10 |Diphenadione |- | | | | |B01AA11 |Tioclomarol |- | | | | |B01AA12 |Fluindione |- | | | |B01AB | |Heparin group |- | | | | |B01AB01 |Heparin |- | | | | |B01AB02 |Antithrombin III |- | | | | |B01AB04 |Dalteparin |- | | | | |B01AB05 |Enoxaparin |- | | | | |B01AB06 |Nadroparin |- | | | | |B01AB07 |Parnaparin |- | | | | |B01AB08 |Reviparin |- | | | | |B01AB09 |Danaparoid |- | | | | |B01AB10 |Tinzaparin |- | | | | |B01AB11 |Sulodexide |- | | | | |B01AB12 |Bemiparin |- | | | | |B01AB51 |Heparin, combinations |- | | | |B01AC | |Platelet aggregation inhibitors excluding heparin |- | | | | |B01AC01 |Ditazole |- | | | | |B01AC02 |Cloricromen |- | | | | |B01AC03 |Picotamide |- | | | | |B01AC04 |Clopidogrel |- | | | | |B01AC05 |Ticlopidine |- | | | | |B01AC06 |Acetylsalicylic acid |- | | | | |B01AC07 |Dipyridamole |- | | | | |B01AC08 |Carbasalate calcium |- | | | | |B01AC09 |Epoprostenol |- | | | | |B01AC10 |Indobufen |- | | | | |B01AC11 |Iloprost |- | | | | |B01AC13 |Abciximab |- | | | | |B01AC15 |Aloxiprin |- | | | | |B01AC16 |Eptifibatide |- | | | | |B01AC17 |Tirofiban |- | | | | |B01AC18 |Triflusal |- | | | | |B01AC19 |Beraprost |- | | | | |B01AC21 |Treprostinil |- | | | | |B01AC22 |Prasugrel |- | | | | |B01AC23 |Cilostazol |- | | | | |B01AC24 |Ticagrelor |- | | | | |B01AC30 |Combinations |- | | | | |B01AC56 |Acetylsalicylic acid and esomeprazole |- | | | |B01AD | |Enzymes |- | | | | |B01AD01 |Streptokinase |- | | | | |B01AD02 |Alteplase |- | | | | |B01AD03 |Anistreplase |- | | | | |B01AD04 |Urokinase |- | | | | |B01AD05 |Fibrinolysin |- | | | | |B01AD06 |Brinase |- | | | | |B01AD07 |Reteplase |- | | | | |B01AD08 |Saruplase |- | | | | |B01AD09 |Ancrod |- | | | | |B01AD10 |Drotrecogin alfa (activated) |- | | | | |B01AD11 |Tenecteplase |- | | | | |B01AD12 |Protein C |- | | | |B01AE | |Direct thrombin inhibitors |- | | | | |B01AE01 |Desirudin |- | | | | |B01AE02 |Lepirudin |- | | | | |B01AE03 |Argatroban |- | | | | |B01AE04 |Melagatran |- | | | | |B01AE05 |Ximelagatran |- | | | | |B01AE06 |Bivalirudin |- | | | | |B01AE07 |Dabigatran etexilate |- | | | |B01AF | |Direct factor Xa inhibitors |- | | | | |B01AF01 |Rivaroxaban |- | | | | |B01AF02 |Apixaban |- | | | |B01AX | |Other antithrombotic agents |- | | | | |B01AX01 |Defibrotide |- | | | | |B01AX04 |Dermatan sulfate |- | | | | |B01AX05 |Fondaparinux |- | |B02 | | | |Antihemorrhagics |- | |B03 | | | |Antianemic preparations |- | |B05 | | | |Blood substitutes and perfusion solutions |- | | |B05A | | |Blood and related products |- | | | |B05AA | |Blood substitutes and plasma protein fractions |- | | | | |B05AA01 |Serum albumin |- | | | | |B05AA02 |Other plasma protein fractions |- | | | | |B05AA03 |Fluorocarbon blood substitutes |- | | | | |B05AA05 |Dextran |- | | | | |B05AA06 |Gelatin agents |- | | | | |B05AA07 |Hydroxyethylstarch |- | | | | |B05AA08 |Hemoglobin crosfumaril |- | | | | |B05AA09 |Hemoglobin raffimer |- | | | | |B05AA10 |Hemoglobin glutamer (bovine) |- | | | |B05AX | |Other blood products |- | | | | |B05AX01 |Erythrocytes |- | | | | |B05AX02 |Thrombocytes |- | | | | |B05AX03 |Blood plasma |- | | | | |B05AX04 |Stem cells from umbilical cord blood |- | | |B05B | | |I.v. solutions |- | | | |B05BA | |Solutions for parenteral nutrition |- | | | | |B05BA01 |Amino acids |- | | | | |B05BA02 |Fat emulsions |- | | | | |B05BA03 |Carbohydrates |- | | | | |B05BA04 |Protein hydrolysates |- | | | | |B05BA10 |Combinations |- | | | |B05BB | |Solutions affecting the electrolyte balance |- | | | | |B05BB01 |Electrolytes |- | | | | |B05BB02 |Electrolytes with carbohydrates |- | | | | |B05BB03 |Trometamol |- | | | | |B05BB04 |Electrolytes in combination with other drugs |- | | | |B05BC | |Solutions producing osmotic diuresis |- | | | | |B05BC01 |Mannitol |- | | | | |B05BC02 |Carbamide |- | | |B05C | | |Irrigating solutions |- | | | |B05CA | |Antiinfectives |- | | | | |B05CA01 |Cetylpyridinium |- | | | | |B05CA02 |Chlorhexidine |- | | | | |B05CA03 |Nitrofural |- | | | | |B05CA04 |Sulfamethizole |- | | | | |B05CA05 |Taurolidine |- | | | | |B05CA06 |Mandelic acid |- | | | | |B05CA07 |Noxytiolin |- | | | | |B05CA08 |Ethacridine lactate |- | | | | |B05CA09 |Neomycin |- | | | | |B05CA10 |Combinations |- | | | |B05CB | |Salt solutions |- | | | | |B05CB01 |Sodium chloride |- | | | | |B05CB02 |Sodium citrate |- | | | | |B05CB03 |Magnesium citrate |- | | | | |B05CB04 |Sodium bicarbonate |- | | | | |B05CB10 |Combinations |- | | | |B05CX | |Other irrigating solutions |- | | | | |B05CX01 |Glucose |- | | | | |B05CX02 |Sorbitol |- | | | | |B05CX03 |Glycine |- | | | | |B05CX04 |Mannitol |- | | | | |B05CX10 |Combinations |- | | |B05D | | |Peritoneal dialytics |- | | | |B05DA | |Isotonic solutions |- | | | |B05DB | |Hypertonic solutions |- | | |B05X | | |I.v. solution additives |- | | | |B05XA | |Electrolyte solutions |- | | | | |B05XA01 |Potassium chloride |- | | | | |B05XA02 |Sodium bicarbonate |- | | | | |B05XA03 |Sodium chloride |- | | | | |B05XA04 |Ammonium chloride |- | | | | |B05XA05 |Magnesium sulfate |- | | | | |B05XA06 |Potassium phosphate, including combinations with other potassium salts |- | | | | |B05XA07 |Calcium chloride |- | | | | |B05XA08 |Sodium acetate |- | | | | |B05XA09 |Sodium phosphate |- | | | | |B05XA10 |Magnesium phosphate |- | | | | |B05XA11 |Magnesium chloride |- | | | | |B05XA12 |Zinc chloride |- | | | | |B05XA13 |Hydrochloric acid |- | | | | |B05XA14 |Sodium glycerophosphate |- | | | | |B05XA15 |Potassium lactate |- | | | | |B05XA16 |Cardioplegia solutions |- | | | | |B05XA17 |Potassium acetate |- | | | | |B05XA30 |Combinations of electrolytes |- | | | | |B05XA31 |Electrolytes in combination with other drugs |- | | | |B05XB | |Amino acids |- | | | | |B05XB01 |Arginine hydrochloride |- | | | | |B05XB02 |Alanyl glutamine |- | | | | |B05XB03 |Lysine |- | | | |B05XC | |Vitamins |- | | | |B05XX | |Other i.v. solution additives |- | | | | |B05XX02 |Trometamol |- | | |B05Z | | |Hemodialytics and hemofiltrates |- | | | |B05ZA | |Hemodialytics, concentrates |- | | | |B05ZB | |Hemofiltrates |- | |B06 | | | |Other hematological agents |- |‏C | | | | |Cardiovascular system ‏ |- | |C01 | | | |Cardiac therapy |- | |C02 | | | |Antihypertensives |- | |C03 | | | |Diuretics |- | |C04 | | | |Peripheral vasodilators |- | |C05 | | | |Vasoprotectives |- | |C07 | | | |Beta blocking agents |- | |C08 | | | |Calcium channel blockers |- | |C09 | | | |Agents acting on the renin-angiotensin system |- | |C10 | | | |Lipid modifying agents |- | | |C10A | | |Lipid modifying agents, plain |- | | | |C10AA | |HMG CoA reductase inhibitors |- | | | |C10AB | |Fibrates |- | | | |C10AC | |Bile acid sequestrants |- | | | | | C10AC01 |Colestyramine |- | | | | |C10AC02 |Colestipol |- | | | | | C10AC03 |Colextran |- | | | | |C10AC04 |Colesevelam |- | | | |C10AD | |Nicotinic acid and derivatives |- | | | |C10AX | |Other lipid modifying agents |- | | |C10B | | |Lipid modifying agents, combinations |- |‏D | | | | |Dermatologicals |- | |D01 | | | |Antifungals for dermatological use |- | |D02 | | | |Emollients and protectives |- | |D03 | | | |Preparations for treatment of wounds and ulcers |- | |D04 | | | |Antipruritics, including antihistamines, anesthetics, etc |- | |D05 | | | |Antipsoriatics |- | |D06 | | | |Antibiotics and chemotherapeutics for dermatological use |- | |D07 | | | |Corticosteroids, dermatological preparations |- | |D08 | | | |Antiseptics and disinfectants |- | |D09 | | | |Medicated dressings |- | |D10 | | | |Anti-acne preparations |- | |D11 | | | |Other dermatological preparations |- |‏G | | | | |Genito-urinary system and sex hormones ‏ |- | |G01 | | | |Gynecological antiinfectives and antiseptics |- | |G02 | | | |Other gynecologicals |- | |G03 | | | |Sex hormones and modulators of the genital system |- | |G04 | | | |Urologicals |- | | |G04B | | |Urologicals |- | | | |G04BA | |Acidifiers |- | | | |G04BC | |Urinary concrement solvents |- | | | |G04BD | |Drugs for urinary frequency and incontinence |- | | | | |G04BD01 |Emepronium |- | | | | |G04BD02 |Flavoxate |- | | | | |G04BD03 |Meladrazine |- | | | | |G04BD04 |Oxybutynin |- | | | | |G04BD05 |Terodiline |- | | | | |G04BD06 |Propiverine |- | | | | |G04BD07 |Tolterodine |- | | | | |G04BD08 |Solifenacin |- | | | | |G04BD09 |Trospium |- | | | | |G04BD10 |Darifenacin |- | | | | |G04BD11 |Fesoterodine |- | | | | |G04BD12 |Mirabegron |- | | | |G04BE | |Drugs used in erectile dysfunction |- | | | | |G04BE01 |Alprostadil |- | | | | |G04BE02 |Papaverine |- | | | | |G04BE03 |Sildenafil |- | | | | |G04BE04 |Yohimbin |- | | | | |G04BE06 |Moxisylyte |- | | | | |G04BE07 |Apomorphine |- | | | | |G04BE08 |Tadalafil |- | | | | |G04BE09 |Vardenafil |- | | | | |G04BE30 |Combinations |- | | | | |G04BE52 |Papaverine, combinations |- | | | |G04BX | |Other urologicals |- | | | | | |להשלים |- | | |G04C | | |Drugs used in benign prostatic hypertrophy |- | | | |G04CA | |Alpha-adrenoreceptor antagonists |- | | | |G04CB | |Testosterone-5-alpha reductase inhibitors |- | | | |G04CX | |Other drugs used in benign prostatic hypertrophy |- |‏H | | | | |Systemic hormonal preparations, excluding sex hormones and insulins ‏ |- | |H01 | | | |Pituitary and hypothalamic hormones and analogues |- | |H02 | | | |Corticosteroids for systemic use |- | |H03 | | | |Thyroid therapy |- | |H04 | | | |Pancreatic hormones |- | |H05 | | | |Calcium homeostasis |- |‏J | | | | |Antiinfectives for systemic use ‏ |- | |J01 | | | |Antibacterials for systemic use |- | | |J01A | | |Tetracyclines |- | | |J01B | | |Amphenicols |- | | |J01C | | |Beta-lactam antibacterials, penicillins |- | | |J01D | | |Other beta-lactam antibacterials |- | | |J01E | | |Sulfonamides and trimethoprim |- | | |J01F | | |Macrolides, lincosamides and streptogramins |- | | |J01G | | |Aminoglycoside antibacterials |- | | |J01M | | |Quinolone antibacterials |- | | |J01R | | |Combinations of antibacterials |- | | |J01X | | |Other antibacterials |- | | | |J01XA | |Glycopeptide antibacterials |- | | | |J01XB | |Polymyxins |- | | | |J01XC | |Steroid antibacterials |- | | | |J01XD | |Imidazole derivatives |- | | | |J01XE | |Nitrofuran derivatives |- | | | | J01XX | |Other antibacterials |- | |J02 | | | |Antimycotics for systemic use |- | |J04 | | | |Antimycobacterials |- | |J05 | | | |Antivirals for systemic use |- | | |J05A | | |Direct acting antiviral drugs |- | | | |J05AA | |Thiosemicarbazones |- | | | |J05AB | |Nucleosides and nucleotides excluding reverse transcriptase inhibitors |- | | | |J05AC | |Cyclic amines |- | | | |J05AD | |Phosphonic acid derivatives |- | | | |J05AE | |Protease inhibitors |- | | | |J05AF | |Nucleoside and nucleotide reverse transcriptase inhibitors |- | | | | |J05AF01 | Zidovudine |- | | | | |J05AF02 | Didanosine |- | | | | |J05AF03 | Zalcitabine |- | | | | |J05AF04 | Stavudine |- | | | | |J05AF05 | Lamivudine |- | | | | |J05AF06 | Abacavir |- | | | | |J05AF07 | Tenofovir disoproxil |- | | | | |J05AF08 | Adefovir dipivoxil |- | | | | |J05AF09 | Emtricitabine |- | | | | |J05AF10 | Entecavir |- | | | | |J05AF11 | Telbivudine |- | | | | |J05AF12 | Clevudine |- | | | |J05AG | |Non-nucleoside reverse transcriptase inhibitors |- | | | | |J05AG01 |Nevirapine |- | | | | |J05AG02 |Delavirdine |- | | | | |J05AG03 |Efavirenz |- | | | | |J05AG04 |Etravirine |- | | | | |J05AG05 |Rilpivirine |- | | | |J05AH | |Neuraminidase inhibitors |- | | | | |J05AH01 |Zanamivir |- | | | | |J05AH02 |Oseltamivir |- | | | |J05AR | |Antivirals for treatment of HIV infections, combinations |- | | | | |J05AR01 |Zidovudine and lamivudine |- | | | | |J05AR02 |Lamivudine and abacavir |- | | | | |J05AR03 |Tenofovir disoproxil and emtricitabine |- | | | | |J05AR04 |Zidovudine, lamivudine and abacavir |- | | | | |J05AR05 |Zidovudine, lamivudine and nevirapine |- | | | | |J05AR06 |Emtricitabine, tenofovir disoproxil and efavirenz |- | | | | |J05AR07 |Stavudine, lamivudine and nevirapine |- | | | | |J05AR08 |Emtricitabine, tenofovir disoproxil and rilpivirine |- | | | | |J05AR09 |Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat |- | | | | |J05AR10 |Lopinavir and ritonavir |- | | | |J05AX | |Other antivirals |- | | | | |J05AX01 |Moroxydine |- | | | | |J05AX02 |Lysozyme |- | | | | |J05AX05 |Inosine pranobex |- | | | | |J05AX06 |Pleconaril |- | | | | |J05AX07 |Enfuvirtide |- | | | | |J05AX08 |Raltegravir |- | | | | |J05AX09 |Maraviroc |- | | | | |J05AX10 |Maribavir |- | | | | |J05AX11 |Elvitegravir |- | |J06 | | | |Immune sera and immunoglobulins |- | | |J06A | | | Immune sera |- | | | |J06AA | | Immune sera |- | | | | |J06AA01 | Diphtheria antitoxin |- | | | | | J06AA02 | Tetanus antitoxin |- | | | | |J06AA03 | Snake venom antiserum |- | | | | | J06AA04 | Botulinum antitoxin |- | | | | |J06AA05 | Gas-gangrene sera |- | | | | | J06AA06 | Rabies serum |- | | |J06B | | | Immunoglobulins |- | | | |J06BA | |Immunoglobulins, normal human |- | | | | |J06BA01 |Immunoglobulins, normal human, for extravascular administration |- | | | | | J06BA02 |Immunoglobulins, normal human, for intravascular administration |- | | | |J06BB | |Specific immunoglobulins |- | | | | |J06BB01 |Anti-D (rh) immunoglobulin |- | | | | |J06BB02 | Tetanus immunoglobulin |- | | | | |J06BB03 | Varicella/zoster immunoglobulin |- | | | | |J06BB04 | Hepatitis B immunoglobulin |- | | | | |J06BB05 | Rabies immunoglobulin |- | | | | | J06BB06 | Rubella immunoglobulin |- | | | | | J06BB07 | Vaccinia immunoglobulin |- | | | | |J06BB08 | Staphylococcus immunoglobulin |- | | | | | J06BB09 | Cytomegalovirus immunoglobulin |- | | | | |J06BB10 | Diphtheria immunoglobulin |- | | | | |J06BB11 | Hepatitis A immunoglobulin |- | | | | |J06BB12 | Encephalitis, tick borne immunoglobulin |- | | | | |J06BB13 | Pertussis immunoglobulin |- | | | | |J06BB14 |Morbilli immunoglobulin |- | | | | |J06BB15 | Parotitis immunoglobulin |- | | | | |J06BB16 | Palivizumab |- | | | | | J06BB17 | Motavizumab |- | | | | |J06BB30 | Combinations |- | | | |J06BC | | Other immunoglobulins |- | | | | |J06BC01 | Nebacumab |- |‏L | | | | |Antineoplastic and immunomodulating agents ‏ |- | |L01 | | | |Antineoplastic agents |- | |L02 | | | |Endocrine therapy |- | |L03 | | | |Immunostimulants |- | |L04 | | | |Immunosuppressants |- |‏M | | | | |Musculo-skeletal system ‏ |- | |M01 | | | |Anti-inflammatory and antirheumatic products |- | | |M01A | | |Anti-inflammatory and antirheumatic products, non-steroids |- | | | |M01AA | |Butylpyrazolidines |- | | | |M01AB | |Acetic acid derivatives and related substances |- | | | | | M01AB01 | Indometacin |- | | | | | M01AB02 | Sulindac |- | | | | | M01AB03 | Tolmetin |- | | | | | M01AB04 | Zomepirac |- | | | | | M01AB05 | Diclofenac |- | | | | | M01AB06 | Alclofenac |- | | | | | M01AB07 | Bumadizone |- | | | | | M01AB08 | Etodolac |- | | | | | M01AB09 | Lonazolac |- | | | | | M01AB10 | Fentiazac |- | | | | | M01AB11 | Acemetacin |- | | | | | M01AB12 | Difenpiramide |- | | | | | M01AB13 | Oxametacin |- | | | | | M01AB14 | Proglumetacin |- | | | | | M01AB15 | Ketorolac |- | | | | | M01AB16 | Aceclofenac |- | | | | | M01AB17 | Bufexamac |- | | | | | M01AB51 | Indometacin, combinations |- | | | | | M01AB55 | Diclofenac, combinations |- | | | |M01AC | |Oxicams |- | | | |M01AE | |Propionic acid derivatives |- | | | |M01AG | |Fenamates |- | | | |M01AH | |Coxibs |- | | | |M01AX | |Other anti-inflammatory and antirheumatic agents, non-steroids |- | | | | |M01AX01  |Nabumetone |- | | | | |M01AX02  |Niflumic acid |- | | | | |M01AX04  |Azapropazone |- | | | | |M01AX05  |Glucosamine |- | | | | |M01AX07  |Benzydamine |- | | | | |M01AX12  |Glucosaminoglycan polysulfate |- | | | | |M01AX13  |Proquazone |- | | | | |M01AX14  |Orgotein |- | | | | |M01AX17  |Nimesulide |- | | | | |M01AX18  |Feprazone |- | | | | |M01AX21  |Diacerein |- | | | | |M01AX22  |Morniflumate |- | | | | |M01AX23  |Tenidap |- | | | | |M01AX24  |Oxaceprol |- | | | | |M01AX25  |Chondroitin sulfate |- | | | | |M01AX26  |Avocado and soyabean oil, unsaponifiables |- | | | | |M01AX68 |Feprazone, combinations |- | | |M01B | | |Anti-inflammatory/antirheumatic agents in combination |- | | |M01C | | |Specific antirheumatic agents |- | |M02 | | | |Topical products for joint and muscular pain |- | | |M02A | | |Topical products for joint and muscular pain |- | | | |M02AA | |Anti-inflammatory preparations, non-steroids for topical use |- | | | | |M02AA01 |Phenylbutazone |- | | | | |M02AA02 |Mofebutazone |- | | | | |M02AA03 |Clofezone |- | | | | |M02AA04 |Oxyphenbutazone |- | | | | |M02AA05 |Benzydamine |- | | | | |M02AA06 |Etofenamate |- | | | | |M02AA07 |Piroxicam |- | | | | |M02AA08 |Felbinac |- | | | | |M02AA09 |Bufexamac |- | | | | |M02AA10 |Ketoprofen |- | | | | |M02AA11 |Bendazac |- | | | | |M02AA12 |Naproxen |- | | | | |M02AA13 |Ibuprofen |- | | | | |M02AA14 |Fentiazac |- | | | | |M02AA15 |Diclofenac |- | | | | |M02AA16 |Feprazone |- | | | | |M02AA17 |Niflumic acid |- | | | | |M02AA18 |Meclofenamic acid |- | | | | |M02AA19 |Flurbiprofen |- | | | | |M02AA21 |Tolmetin |- | | | | |M02AA22 |Suxibuzone |- | | | | |M02AA23 |Indometacin |- | | | | |M02AA24 |Nifenazone |- | | | | |M02AA25 |Aceclofenac |- | | | | |M02AA26 |Nimesulide |- | | | |M02AB | |Capsaicin and similar agents |- | | | |M02AC | |Preparations with salicylic acid derivatives |- | | | |M02AX | |Other topical products for joint and muscular pain |- | |M03 | | | |Muscle relaxants |- | |M04 | | | |Antigout preparations |- | |M05 | | | |Drugs for treatment of bone diseases |- | |M09 | | | |Other drugs for disorders of the musculo-skeletal system |- |‏N | | | | |Nervous system ‏ |- | |N01 | | | | Anesthetics |- | |N02 | | | | Analgesics |- | |N03 | | | | Antiepileptics |- | |N04 | | | |Anti-parkinson drugs |- | |N05 | | | | Psycholeptics |- | | |N05A | | | Antipsychotics |- | | | |N05AA | |Phenothiazines with aliphatic side-chain |- | | | |N05AB | |Phenothiazines with piperazine structure |- | | | |N05AC | |Phenothiazines with piperidine structure |- | | | |N05AD | |Butyrophenone derivatives |- | | | |N05AE | |Indole derivatives |- | | | |N05AF | |Thioxanthene derivative |- | | | |N05AG | |Diphenylbutylpiperidine derivatives |- | | | |N05AH | |Diazepines, oxazepines, thiazepines and oxepines |- | | | |N05AL | |Benzamides |- | | | |N05AN | |Lithium |- | | | |N05AX | |Other antipsychotics |- |- | | | | | N05AX07 |Prothipendyl |- | | | | |N05AX08 |Risperidone |- | | | | |N05AX10 |Mosapramine |- | | | | |N05AX11 |Zotepine |- | | | | |N05AX12 |Aripiprazole |- | | | | |N05AX13 |Paliperidone |- | | | | |N05AX14 |Iloperidone |- | | |N05B | | | Anxiolytics |- | | |N05C | | | Hypnotics and sedatives |- | |N06 | | | | Psychoanaleptics |- | |N07 | | | | Other nervous system drugs |- |‏P | | | | |Antiparasitic products, insecticides and repellents ‏ |- | |P01 | | | |Antiprotozoals |- | |P02 | | | |Anthelmintics |- | |P03 | | | |Ectoparasiticides, including scabicides, insecticides and repellents |- |‏R | | | | |Respiratory system ‏ |- | |R01 | | | |Nasal preparations |- | |R02 | | | |Throat preparations |- | |R03 | | | |Drugs for obstructive airway diseases |- | |R05 | | | |Cough and cold preparations |- | |R06 | | | |Antihistamines for systemic use |- | |R07 | | | |Other respiratory system products |- |‏S | | | | |Sensory organs ‏ |- | |S01 | | | | Ophthalmologicals |- | |S02 | | | |Otologicals |- | |S03 | | | |Ophthalmological and otological preparations |- |‏V | | | | |Various‏ |- | |V01 | | | |Allergens |- | |V03 | | | |All other therapeutic products |- | |V04 | | | |Diagnostic agents |- | |V06 | | | |General nutrients |- | |V07 | | | |All other non-therapeutic products |- | |V08 | | | |Contrast media |- | |V09 | | | |Diagnostic radiopharmaceuticals |- | |V10 | | | |Therapeutic radiopharmaceuticals |- | |V20 | | | |Surgical dressings |}

ביבליוגרפיה